Skip to content

Atrial Fibrillation and Premature Atrial Complexes in Patients With Ischemic Stroke.

Atrial Fibrillation and Premature Atrial Complexes in Patients With Ischemic Stroke: Prevalence, Characteristics and Prognosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02180542
Acronym
Pacific
Enrollment
264
Registered
2014-07-02
Start date
2012-03-31
Completion date
2016-10-31
Last updated
2017-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Premature Atrial Complexes, Stroke

Keywords

stroke, Ischemic stroke, Cerebral infarction, recurrent stroke, atrial fibrillation, premature atrial complexes, heart rhythm monitoring, left atrial function, carotid artery, plaque morphology

Brief summary

The purpose of this study is to improve secondary prevention of ischemic stroke patients by 1. Estimating prevalence and the prognostic significance of frequent premature atrial complexes in ischemic stroke patients in relation to death, recurrent stroke and atrial fibrillation. 2. Characterize ischemic stroke patients by 1. Echocardiographic characteristics 2. Biochemical markers 3. Plaque composition in the carotid arteries * in order to improve risk stratification.

Detailed description

Patients with atrial fibrillation (AF) have a five-fold increased risk of ischemic stroke compared to the general population. Identifying AF can be challenging, but prolonged rhythm monitoring of ischemic stroke patients have shown to enhance detection rates of AF. Therefore it is important to identify predictors of AF to allow targeted screening of patients after ischemic stroke and thereby reduce the recurrent stroke rate. Few former studies have shown an association between excessive numbers of premature atrial complexes (PACs) and AF. The study population of ischemic stroke patients will at admission undergo following examinations: 1. ECG 2. 48 hours inpatient cardiac telemetry (If not known AF) 3. 24 hours holter monitoring (if not known AF) 4. echocardiogram 5. blood sample 6. CT scan of carotid arteries with contrast made on Dual Energy CT scan. In the follow-up period, patients will have two visits with 48 hour holter monitoring (after 6 and 12 months, respectively) It will be noticed if patients have any recurrent events, die og developing AF. The study population will be divided into four groups as follows: 1. patients with new AF at admission 2. patients with known AF 3. patients with frequent PACs 4. patients without frequent PACs. These groups will be compared on baseline characteristics and on outcome as mentioned. The overall perspective is to make better strategies for detecting occult AF after ischemic stroke to improve secondary stroke prevention care.

Interventions

None listed

Sponsors

University of Southern Denmark
CollaboratorOTHER
Odense University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* admitted with ischemic stroke at a single center * time from diagnose to inclusion maximum 7 days. * written informed consent or surrogate informed consent eligible * age \> 18 years.

Exclusion criteria

* hemorrhagic stroke * terminal illness and expected lifespan of less than 6 months. * any physical or mental condition which make the patients unsuitable for participation in the study. * known with a pacemaker * anticoagulation treatment of other reasons than atrial fibrillation.

Design outcomes

Primary

MeasureTime frame
time to death and recurrent strokeUp to 4 years

Secondary

MeasureTime frameDescription
Time to death, recurrent stroke and atrial fibrillationUp to 4 years
Left atrial volume and function estimated by echocardiographybaselinedescriptive comparison in between groups.

Other

MeasureTime frameDescription
biochemical markersbaselinedescriptive comparison in between groups
Plaque analysis i the carotid arteries on CTbaselinedescriptive comparison in between groups.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026